Login
or
Log in
now
Front Page
Console
Blog a Stock
Most Popular
Newest
Leaderboard
Random
About Us
Sectors
>
Healthcare
>
Diagnostic Substances
>
OGXI
OGXI
OncoGenex Pharmaceuticals
Research
Consider this Stock
so you get emails when someone covers it
Last
Change
Change %
Open
Volume
Low
High
OGXI
9.50
-0.53
0.0%
0.00
0
0.00
0.00
To see this stock chart, please enable scripting for wikinvest.com or
click here to download Flash
From the Wires...
Community Links
Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy
us.rd.yahoo.com/.../1500912-near-a-52-week-low-is-oncogenex-pharmaceuticals-a-buy
6/13/13
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
us.rd.yahoo.com/.../...-inc-provides-clinical-200100531.html
5/2/13 [CNW Group] - OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
us.rd.yahoo.com/.../...-inc-provides-clinical-200000960.html
5/2/13 [PR Newswire] - BOTHELL, Wash. and VANCOUVER, British Columbia, May 2, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided an overview of clinical development...
OncoGenex Announces Plans for the Initiation of the Rainier Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer
us.rd.yahoo.com/.../...ans-initiation-rainier-103000489.html
5/1/13 [PR Newswire] - BOTHELL, Wash. and VANCOUVER, British Columbia, May 1, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the...
OncoGenex Announces that the Borealis-2 Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment
us.rd.yahoo.com/.../...es-borealis-2-clinical-120000464.html
4/30/13 [PR Newswire] - BOTHELL, Wash. and VANCOUVER, British Columbia, April 30, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced initiation of the Borealis-2?...
Be the first to blog OGXI
Enter a Symbol
Set a Target Price
or Set % Change
Choose a Target Date
Once you have entered a symbol, information about that security will appear here.
© ProofTrader 2012
Proof Console
Blog a Stock
Feature Writers
About Us
Terms & Conditions
Feedback